Fecal microbiota transplantation in human metabolic diseases: From a murky past to a bright future?

[1]  W. D. de Vos,et al.  Fecal Microbiota Transplantation from Overweight or Obese Donors in Cachectic Patients with Advanced Gastroesophageal Cancer: A Randomized, Double-blind, Placebo-Controlled, Phase II Study , 2021, Clinical Cancer Research.

[2]  Keli Yang,et al.  Microbiota engraftment after faecal microbiota transplantation in obese subjects with type 2 diabetes: a 24-week, double-blind, randomised controlled trial , 2021, Gut.

[3]  Y. Furukawa,et al.  Functional Restoration of Bacteriomes and Viromes by Fecal Microbiota Transplantation. , 2021, Gastroenterology.

[4]  J. Badger,et al.  Fecal microbiota transplant overcomes resistance to anti–PD-1 therapy in melanoma patients , 2021, Science.

[5]  M. Nieuwdorp,et al.  Compensatory intestinal immunoglobulin response after vancomycin treatment in humans , 2021, Gut microbes.

[6]  W. D. de Vos,et al.  Gut bacteriophage dynamics during fecal microbial transplantation in subjects with metabolic syndrome , 2021, Gut microbes.

[7]  N. Ajami,et al.  Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients , 2020, Science.

[8]  N. Sachdeva,et al.  Butyrate induced Tregs are capable of migration from the GALT to the pancreas to restore immunological tolerance during type-1 diabetes , 2020, Scientific Reports.

[9]  M. Ege,et al.  Maturation of the gut microbiome during the first year of life contributes to the protective farm effect on childhood asthma , 2020, Nature Medicine.

[10]  R. Knight,et al.  Host variables confound gut microbiota studies of human disease , 2020, Nature.

[11]  A. Zwinderman,et al.  Faecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a randomised controlled trial , 2020, Gut.

[12]  P. Hegyi,et al.  Fecal Microbiota Transplantation May Be the Best Option in Treating Multiple Clostridioides difficile Infection: A Network Meta-Analysis , 2020, Infectious Diseases and Therapy.

[13]  E. Zoetendal,et al.  Donor Fecal Microbiota Transplantation Alters Gut Microbiota and Metabolites in Obese Individuals With Steatohepatitis , 2020, Hepatology communications.

[14]  W. D. de Vos,et al.  Maternal Fecal Microbiota Transplantation in Cesarean-Born Infants Rapidly Restores Normal Gut Microbial Development: A Proof-of-Concept Study , 2020, Cell.

[15]  S. L. la Fleur,et al.  Infusion of donor feces affects the gut–brain axis in humans with metabolic syndrome , 2020, Molecular metabolism.

[16]  R. Finn,et al.  Massive expansion of human gut bacteriophage diversity , 2020, Cell.

[17]  F. Hu,et al.  Effects of Diet-Modulated Autologous Fecal Microbiota Transplantation on Weight Regain. , 2020, Gastroenterology.

[18]  S. Gibbons.  Keystone taxa indispensable for microbiome recovery , 2020, Nature Microbiology.

[19]  B. Blom,et al.  Donor fecal microbiota transplantation ameliorates intestinal graft-versus-host disease in allogeneic hematopoietic cell transplant recipients , 2020, Science Translational Medicine.

[20]  E. Savarino,et al.  Faecal microbiota transplantation in Clostridioides difficile infection: real-life experience from an academic Italian hospital , 2020, Therapeutic advances in gastroenterology.

[21]  Trevor C. Charles,et al.  Microbiome definition re-visited: old concepts and new challenges , 2020, Microbiome.

[22]  A. Basson,et al.  Autologous fecal microbiota transplantation for the treatment of inflammatory bowel disease , 2020, Translational Research.

[23]  H. Neve,et al.  Bacteriophage-mediated manipulation of the gut microbiome - promises and presents limitations. , 2020, FEMS microbiology reviews.

[24]  I. Kaur,et al.  Delivery routes for faecal microbiota transplants: Available, anticipated and aspired. , 2020, Pharmacological research.

[25]  C. McKenzie,et al.  Allogenic Fecal Microbiota Transplantation in Patients With Nonalcoholic Fatty Liver Disease Improves Abnormal Small Intestinal Permeability: A Randomized Control Trial. , 2020, The American journal of gastroenterology.

[26]  Namhee Kim,et al.  The human gut archaeome: identification of diverse haloarchaea in Korean subjects , 2020, Microbiome.

[27]  Bing Han,et al.  COVID-19: Gastrointestinal Manifestations and Potential Fecal–Oral Transmission , 2020, Gastroenterology.

[28]  M. Henn,et al.  Fecal microbiota transplantation for the improvement of metabolism in obesity: The FMT-TRIM double-blind placebo-controlled pilot trial , 2020, PLoS medicine.

[29]  M. Netea,et al.  Oral butyrate does not affect innate immunity and islet autoimmunity in individuals with longstanding type 1 diabetes: a randomised controlled trial , 2020, Diabetologia.

[30]  Miriam H. Huntley,et al.  Drug-Resistant E. coli Bacteremia Transmitted by Fecal Microbiota Transplant. , 2019, The New England journal of medicine.

[31]  H. Tilg,et al.  International consensus conference on stool banking for faecal microbiota transplantation in clinical practice , 2019, Gut.

[32]  Aleksandra A. Kolodziejczyk,et al.  Diet–microbiota interactions and personalized nutrition , 2019, Nature Reviews Microbiology.

[33]  J. Venter,et al.  Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease. , 2019, Cell metabolism.

[34]  J. Ilonen,et al.  Genetic risk for autoimmunity is associated with distinct changes in the human gut microbiome , 2019, Nature Communications.

[35]  A. Kengne,et al.  Higher adherence to plant-based diets are associated with lower likelihood of fatty liver. , 2019, Clinical nutrition.

[36]  Evgeni Levin,et al.  Donor metabolic characteristics drive effects of faecal microbiota transplantation on recipient insulin sensitivity, energy expenditure and intestinal transit time , 2019, Gut.

[37]  S. Wesselingh,et al.  Bacterial viability in faecal transplants: Which bacteria survive? , 2019, EBioMedicine.

[38]  Peer Bork,et al.  Extensive transmission of microbes along the gastrointestinal tract , 2019, eLife.

[39]  Thomas B. Clarke,et al.  Microbial bile salt hydrolases mediate the efficacy of faecal microbiota transplant in the treatment of recurrent Clostridioides difficile infection , 2019, Gut.

[40]  T. Vatanen,et al.  The Super-Donor Phenomenon in Fecal Microbiota Transplantation , 2019, Front. Cell. Infect. Microbiol..

[41]  J. Andrews,et al.  Effect of Fecal Microbiota Transplantation on 8-Week Remission in Patients With Ulcerative Colitis: A Randomized Clinical Trial , 2019, JAMA.

[42]  J. Bajaj.  Alcohol, liver disease and the gut microbiota , 2019, Nature Reviews Gastroenterology & Hepatology.

[43]  M. Nieuwdorp,et al.  Weight Gain after Fecal Microbiota Transplantation in a Patient with Recurrent Underweight following Clinical Recovery from Anorexia Nervosa , 2019, Psychotherapy and Psychosomatics.

[44]  R. Knight,et al.  Preserving microbial diversity , 2018, Science.

[45]  E. Robilotti,et al.  Reconstitution of the gut microbiota of antibiotic-treated patients by autologous fecal microbiota transplant , 2018, Science Translational Medicine.

[46]  Itai Sharon,et al.  Post-Antibiotic Gut Mucosal Microbiome Reconstitution Is Impaired by Probiotics and Improved by Autologous FMT , 2018, Cell.

[47]  V. Tremaroli,et al.  Depicting the composition of gut microbiota in a population with varied ethnic origins but shared geography , 2018, Nature Medicine.

[48]  H. Adami,et al.  Fecal Microbiota Transplantation for Primary Clostridium difficile Infection. , 2018, The New England journal of medicine.

[49]  E. Holmes,et al.  A Prospective Metagenomic and Metabolomic Analysis of the Impact of Exercise and/or Whey Protein Supplementation on the Gut Microbiome of Sedentary Adults , 2018, mSystems.

[50]  J. Skyler.  Hope vs hype: where are we in type 1 diabetes? , 2018, Diabetologia.

[51]  D. Kao,et al.  Early Antibiotic Use After Fecal Microbiota Transplantation Increases Risk of Treatment Failure , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[52]  W. D. de Vos,et al.  Akkermansia muciniphila induces gut microbiota remodelling and controls islet autoimmunity in NOD mice , 2017, Gut.

[53]  W. D. de Vos,et al.  Distinct fecal and oral microbiota composition in human type 1 diabetes, an observational study , 2017, PloS one.

[54]  S. Taylor-Robinson,et al.  Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: A randomized clinical trial , 2017, Hepatology.

[55]  M. Packer.  Are Meta-Analyses a Form of Medical Fake News?: Thoughts About How They Should Contribute to Medical Science and Practice , 2017, Circulation.

[56]  G. Kaplan,et al.  Effect of Oral Capsule– vs Colonoscopy-Delivered Fecal Microbiota Transplantation on Recurrent Clostridium difficile Infection: A Randomized Clinical Trial , 2017, JAMA.

[57]  Evgeni Levin,et al.  Improvement of Insulin Sensitivity after Lean Donor Feces in Metabolic Syndrome Is Driven by Baseline Intestinal Microbiota Composition. , 2017, Cell metabolism.

[58]  M. Blaser.  The theory of disappearing microbiota and the epidemics of chronic diseases , 2017, Nature Reviews Immunology.

[59]  P. Engen,et al.  Relationships between gastrointestinal microbiota and blood group antigens. , 2017, Physiological genomics.

[60]  J. Andrews,et al.  Systematic review with meta‐analysis: faecal microbiota transplantation for the induction of remission for active ulcerative colitis , 2017, Alimentary pharmacology & therapeutics.

[61]  S. Schreiber,et al.  Efficacy of Sterile Fecal Filtrate Transfer for Treating Patients With Clostridium difficile Infection. , 2017, Gastroenterology.

[62]  Linfeng Yang,et al.  Fecal microbiota transplantation in patients with slow-transit constipation: A randomized, clinical trial , 2017, PloS one.

[63]  H. Tilg,et al.  European consensus conference on faecal microbiota transplantation in clinical practice , 2017, Gut.

[64]  A. Keshteli,et al.  Pretreatment with antibiotics may enhance the efficacy of fecal microbiota transplantation in ulcerative colitis: a meta-analysis , 2016, Mucosal Immunology.

[65]  D. Pardi,et al.  Donor Screening Experience for Fecal Microbiota Transplantation in Patients With Recurrent C. difficile Infection , 2016, Journal of clinical gastroenterology.

[66]  M. Hattori,et al.  Fecal microbiota transplantation for patients with steroid-resistant acute graft-versus-host disease of the gut. , 2016, Blood.

[67]  W. D. de Vos,et al.  Long-term effects on luminal and mucosal microbiota and commonly acquired taxa in faecal microbiota transplantation for recurrent Clostridium difficile infection , 2016, BMC Medicine.

[68]  Benjamin Bolduc,et al.  Healthy human gut phageome , 2016, Proceedings of the National Academy of Sciences.

[69]  Dan Knights,et al.  Antibiotic-mediated gut microbiome perturbation accelerates development of type 1 diabetes in mice , 2016, Nature Microbiology.

[70]  S. Bordenstein,et al.  Fecal Transplants: What Is Being Transferred? , 2016, PLoS biology.

[71]  Morris A. Swertz,et al.  Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity , 2016, Science.

[72]  P. Bork,et al.  Durable coexistence of donor and recipient strains after fecal microbiota transplantation , 2016, Science.

[73]  Ron Milo,et al.  Are We Really Vastly Outnumbered? Revisiting the Ratio of Bacterial to Host Cells in Humans , 2016, Cell.

[74]  P. Moayyedi,et al.  Frozen vs Fresh Fecal Microbiota Transplantation and Clinical Resolution of Diarrhea in Patients With Recurrent Clostridium difficile Infection: A Randomized Clinical Trial. , 2016, JAMA.

[75]  Jens Roat Kultima,et al.  Disentangling the effects of type 2 diabetes and metformin on the human gut microbiota , 2016 .

[76]  M. Surette,et al.  Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial. , 2015, Gastroenterology.

[77]  Leo Lahti,et al.  Fat, Fiber and Cancer Risk in African Americans and Rural Africans , 2015, Nature Communications.

[78]  C. Kelly,et al.  Weight Gain After Fecal Microbiota Transplantation , 2015, Open forum infectious diseases.

[79]  D. Fan,et al.  Fecal microbiota transplantation through mid‐gut for refractory Crohn's disease: Safety, feasibility, and efficacy trial results , 2015, Journal of gastroenterology and hepatology.

[80]  Max Nieuwdorp,et al.  Insights Into the Role of the Microbiome in Obesity and Type 2 Diabetes , 2014, Diabetes Care.

[81]  W. D. de Vos,et al.  Fecal Transplantation Treatment of Antibiotic-Induced, Noninfectious Colitis and Long-Term Microbiota Follow-Up , 2014, Case reports in medicine.

[82]  G. Rogler,et al.  Smoking Cessation Alters Intestinal Microbiota: Insights from Quantitative Investigations on Human Fecal Samples Using FISH , 2014, Inflammatory bowel diseases.

[83]  M. Blaser,et al.  Altering the Intestinal Microbiota during a Critical Developmental Window Has Lasting Metabolic Consequences , 2014, Cell.

[84]  K. Shannon,et al.  Gut feelings about smoking and coffee in Parkinson's disease , 2014, Movement disorders : official journal of the Movement Disorder Society.

[85]  Marten Scheffer,et al.  Tipping elements in the human intestinal ecosystem , 2014, Nature Communications.

[86]  E. Zoetendal,et al.  Effect of diet on the intestinal microbiota and its activity , 2014, Current opinion in gastroenterology.

[87]  W. D. de Vos,et al.  Impact of diet on human intestinal microbiota and health. , 2014, Annual review of food science and technology.

[88]  S. Tims,et al.  Reset of a critically disturbed microbial ecosystem: faecal transplant in recurrent Clostridium difficile infection , 2014, The ISME Journal.

[89]  Lawrence A. David,et al.  Diet rapidly and reproducibly alters the human gut microbiome , 2013, Nature.

[90]  Willem M. de Vos,et al.  Genomics: A gut prediction , 2013, Nature.

[91]  L. Rigottier-Gois,et al.  Dysbiosis in inflammatory bowel diseases: the oxygen hypothesis , 2013, The ISME Journal.

[92]  W. M. Vos.  Fame and future of faecal transplantations — developing next-generation therapies with synthetic microbiomes , 2013, Microbial Biotechnology.

[93]  E. Zoetendal,et al.  Duodenal infusion of donor feces for recurrent Clostridium difficile. , 2013, The New England journal of medicine.

[94]  T. Klaenhammer,et al.  Characterization of the Fecal Microbiota Using High-Throughput Sequencing Reveals a Stable Microbial Community during Storage , 2012, PloS one.

[95]  E. Zoetendal,et al.  Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. , 2012, Gastroenterology.

[96]  J. Bluestone,et al.  Control of TH17 cells occurs in the Small Intestine , 2011, Nature.

[97]  R. Knight,et al.  Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns , 2010, Proceedings of the National Academy of Sciences.

[98]  G. Rook.  99th Dahlem Conference on Infection, Inflammation and Chronic Inflammatory Disorders: Darwinian medicine and the ‘hygiene’ or ‘old friends’ hypothesis , 2010, Clinical and experimental immunology.

[99]  P. Bork,et al.  A human gut microbial gene catalogue established by metagenomic sequencing , 2010, Nature.

[100]  W. D. de Vos,et al.  Genetic Diversity of Viable, Injured, and Dead Fecal Bacteria Assessed by Fluorescence-Activated Cell Sorting and 16S rRNA Gene Analysis , 2005, Applied and Environmental Microbiology.

[101]  A M Stephen,et al.  The microbial contribution to human faecal mass. , 1980, Journal of medical microbiology.

[102]  Falk Hildebrand,et al.  Enterotypes in the landscape of gut microbial community composition , 2017, Nature Microbiology.

[103]  Jens Roat Kultima,et al.  Disentangling the effects of type 2 diabetes and metformin on the human gut microbiota , 2015, Nature.

[104]  L. Brandt,et al.  Should We Standardize the 1,700-Year-Old Fecal Microbiota Transplantation? , 2012, The American Journal of Gastroenterology.

[105]  F. Schaffner,et al.  Nonalcoholic fatty liver disease. , 1986, Progress in liver diseases.

[106]  in in Humans. , 2021 .